Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Spero therapeutics, inc. crawled time : 12:07 save search
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-06-01 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 1.52%
H: 16.07%
C: 8.0%
granted grant nasdaq
Spero Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference
Published: 2020-06-01 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 1.52%
H: 16.07%
C: 8.0%
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-06-30 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: -0.22%
H: 1.56%
C: -1.85%
granted grant nasdaq
Spero Therapeutics to Provide Business Update and Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020
Published: 2020-07-29 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: -1.08%
H: 3.78%
C: 2.61%
results
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-07-31 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
| Email alert
Add to watchlist
granted grant nasdaq
Spero Therapeutics Announces Second Quarter 2020 Operating Results and Provides Business Update
Published: 2020-08-06 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 0.32%
H: 6.72%
C: 1.96%
results
Spero Therapeutics Announces FDA Acceptance of IND Application for SPR720
Published: 2020-08-31 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 4.76%
H: 2.5%
C: -1.27%
fda fda acceptance application therapeutics
Spero Therapeutics Announces Positive Topline Results from its Phase 3 ADAPT-PO Clinical Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis
Published: 2020-09-08 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 3.35%
H: 54.43%
C: 41.14%
positive results phase 3 trial topline injection infections
Spero Therapeutics Announces Proposed Public Offering
Published: 2020-09-09 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: -3.87%
H: 0.65%
C: -9.59%
offering therapeutics publication
Spero Therapeutics Announces Pricing of Securities Offering
Published: 2020-09-11 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: -10.57%
H: 4.07%
C: -0.35%
offering therapeutics
Spero Therapeutics to Present at Investor Conferences in September
Published: 2020-09-15 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 1.91%
H: 2.46%
C: -1.48%
conference presentation therapeutics
Spero Therapeutics Hosting Key Opinion Leader Call on Oral Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections
Published: 2020-09-24 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: -0.64%
H: 4.16%
C: 0.21%
treatment injection infections
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-09-30 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 1.88%
H: 4.99%
C: 2.46%
granted grant nasdaq
Spero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020
Published: 2020-10-16 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: -0.38%
H: 2.08%
C: 0.23%
program
Spero Therapeutics to Provide Business Update and Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020
Published: 2020-10-29 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 1.97%
H: 1.63%
C: -0.37%
results
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-11-03 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 2.06%
H: 7.33%
C: 5.83%
granted grant nasdaq
Spero Therapeutics Announces Third Quarter 2020 Operating Results and Provides Business Update
Published: 2020-11-05 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 0.07%
H: 1.94%
C: -1.58%
results
Spero Therapeutics to Present at the Evercore ISI HealthCONx Conference on December 3, 2020
Published: 2020-11-30 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 1.02%
H: 1.78%
C: -1.95%
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2020-11-30 (Crawled : 12:07) - globenewswire.com
SPRO | $1.41 -1.74% -1.77% 110K
|
Health Technology
|
| O: 1.93%
H: 2.49%
C: 0.53%
granted grant nasdaq
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.